CISPLATIN Safety Questions, CISPLATIN Answers


More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about CISPLATIN. Our extensive database of CISPLATIN adverse events and CISPLATIN warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements
Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about CISPLATIN

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet




CISPLATIN Safety Reports

Total CISPLATIN reports: 1173.
CISPLATIN FDA safety alerts: No.
Reported deaths: 296    Reported hospitalizations: 953.
Take CISPLATIN Side Effects Survey or Share Your CISPLATIN Story. Read More Here.

Showing 1-75 of 1173 Next >

Consumer or non-health professional from UNITED STATES reported CISPLATIN problem on Feb 05, 2007. Female patient, 58 years of age, weighting 130.1 lb, was diagnosed with non-small cell lung cancer and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: dehydration, tooth abscess. CISPLATIN dosage: unknown. During the same period patient was treated with GEMCITABINE, ALLOPURINOL, DEXAMETHASONE, PANTOPRAZOLE. Patient was hospitalized. Patient recovered.

CISPLATIN problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 06, 2007. Female patient, weighting 103.0 lb, was diagnosed with endometrial cancer recurrent and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: neutropenia. CISPLATIN dosage: 69.7 MG CDDP: 50MG/M2 50MG/M2 DAY 1. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE, TAXOL. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CISPLATIN problem on Feb 06, 2007. Male patient, 57 years of age, was diagnosed with gastric cancer, anaemia, hypokalaemia, diarrhoea and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: dehydration, febrile neutropenia, malignant neoplasm progression. CISPLATIN dosage: unknown. During the same period patient was treated with IRON SULPHATETHIAMIN COMPOUND, POTASSIUM SUPPLEMENT, LOPERAMIDE. Patient was hospitalized. Patient died on 11/21/2006.

CISPLATIN problem was reported by a Health Professional from UNITED STATES on Feb 06, 2007. Male patient, 60 years of age, was diagnosed with oesophageal adenocarcinoma, blood pressure, insomnia, neuropathy, diabetes mellitus and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: renal failure acute. CISPLATIN dosage: unknown. During the same period patient was treated with FLUOROURACIL, COUMADIN, NORVASC, AMBIEN, LASIX, NEURONTIN, INSULIN, GLYBURIDE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CISPLATIN problem on Feb 07, 2007. Female patient, weighting 45.19 lb, was diagnosed with bone sarcoma and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: abdominal pain, anorexia, congestive cardiomyopathy, fatigue, hepatic function abnormal, hypotension, metabolic acidosis. CISPLATIN dosage: 384 MG. During the same period patient was treated with METHOTREXATE. Patient was hospitalized. Patient recovered.

CISPLATIN problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 07, 2007. Male patient, weighting 194.0 lb, was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: neutrophil count decreased. CISPLATIN dosage: 124 MG. During the same period patient was treated with ETOPOSIDE. Patient recovered.

Health Professional from UNITED STATES reported CISPLATIN problem on Feb 07, 2007. Female patient, 64 years of age, weighting 169.8 lb, was diagnosed with squamous cell carcinoma and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: anorexia, dehydration, dysphagia, nausea, salivary gland disorder, vomiting. CISPLATIN dosage: unknown. During the same period patient was treated with COMPAZINE, DECADRON, HYDROCODONE, PAXIL, SENNA, ZOFRAN. Patient was hospitalized. Patient recovered.

CISPLATIN problem was reported by a Consumer or non-health professional from GERMANY on Feb 07, 2007. Male patient, 72 years of age, was diagnosed with non-small cell lung cancer, atrial fibrillation and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: anaemia, circulatory collapse, thrombocytopenia. CISPLATIN dosage: unknown. During the same period patient was treated with GEMCITABINE, SINTROM MITIS, FUROSEMIDE, SELOKEEN, ENALAPRIL MALEATE, VITAMIN B, LANOXIN, DEXAMETHASONE. Patient was hospitalized. Patient died on 10/26/2006.

Consumer or non-health professional from UNITED STATES reported CISPLATIN problem on Feb 08, 2007. Female patient, weighting 146.4 lb, was diagnosed with cervix carcinoma and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: electrolyte imbalance, fatigue, hypotension, muscle spasms, urinary tract infection. CISPLATIN dosage: 44 MG. During the same period patient was treated with TAXOL, ALBUTEROL, ATIVAN, EMEND, MACRODANTIN, MAGNESIUM, PHENERGAN, POTASSIUM CHLORIDE. Patient was hospitalized. Patient recovered.

CISPLATIN problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 07, 2007. Female patient, weighting 109.3 lb, was diagnosed with cervix carcinoma recurrent and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: neutrophil count decreased. CISPLATIN dosage: 439.5 MG. During the same period patient was treated with TAXOL. Patient recovered.

Consumer or non-health professional from GERMANY reported CISPLATIN problem on Jan 30, 2007. Male patient was diagnosed with seminoma and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: cardiomyopathy. CISPLATIN dosage: unknown. During the same period patient was treated with ETOPOSIDE, BLEOMYCIN. Patient recovered.

CISPLATIN problem was reported by a Consumer or non-health professional from GERMANY on Feb 07, 2007. Male patient, 72 years of age, was diagnosed with non-small cell lung cancer, atrial fibrillation and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: anaemia, circulatory collapse, thrombocytopenia. CISPLATIN dosage: unknown. During the same period patient was treated with GEMCITABINE, SINTROM MITIS, FUROSEMIDE, SELOKEEN, ENALAPRIL MALEATE, VITAMIN B, LANOXIN, DEXAMETHASONE. Patient was hospitalized. Patient died on 10/26/2006.

Consumer or non-health professional from UNITED STATES reported CISPLATIN problem on Feb 07, 2007. Male patient, 57 years of age, weighting 132.3 lb, was diagnosed with non-small cell lung cancer and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: leukopenia, thrombocytopenia, tooth infection. CISPLATIN dosage: unknown. During the same period patient was treated with GEMCITABINE. Patient was hospitalized. Patient died on 01/26/2007.

CISPLATIN problem was reported by a Physician from ARGENTINA on Feb 06, 2007. Male patient, 67 years of age, weighting 154.8 lb, was diagnosed with lung neoplasm malignant, prophylaxis, prophylaxis of nausea and vomiting and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, blood urea increased, depressed level of consciousness, dyspnoea, respiratory disorder. CISPLATIN dosage: 75 MG/M2, EVERY THREE WEEKS. During the same period patient was treated with PEMETREXED, FOLIC ACID, VITAMIN B, ONDANSETRON, TRAMADOL, ENALAPRIL MALEATE, RANITIDINE, DEXAMETHASONE. Patient died on 02/06/2005.

Pharmacist from UNITED STATES reported CISPLATIN problem on Feb 14, 2007. Male patient, 60 years of age, weighting 169.0 lb, was diagnosed with laryngeal cancer and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: renal failure acute. CISPLATIN dosage: 189MG (100MG/M2) IVPB IN 500 ML NS; 1 CYCLE. Patient was hospitalized. Patient recovered.

CISPLATIN problem was reported by a Physician from JAPAN on Feb 01, 2007. Female patient, 53 years of age, was diagnosed with ovarian epithelial cancer, interstitial lung disease and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: colitis, interstitial lung disease, large intestine perforation, neoplasm progression, white blood cell count increased. CISPLATIN dosage: 85 MG ON DAY 1, UNK. During the same period patient was treated with PREDNISOLONE, METHYLPREDNISOLONE, IRINOTECAN. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CISPLATIN problem on Feb 14, 2007. Female patient, weighting 168.7 lb, was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: blood magnesium decreased. CISPLATIN dosage: 80 MG. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE, TAXOL. Patient recovered.

CISPLATIN problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 09, 2007. Female patient, 33 years of age, was diagnosed with gastric cancer, mucosal inflammation and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia, stomatitis. CISPLATIN dosage: unknown. During the same period patient was treated with FLUOROURACIL, MOUTHWASH. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CISPLATIN problem on Feb 09, 2007. Female patient, 73 years of age, was diagnosed with prophylaxis, nausea and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: anaemia, blood albumin decreased, blood alkaline phosphatase increased, blood calcium decreased, blood fibrinogen increased, blood glucose increased, blood lactate dehydrogenase increased, blood potassium decreased. CISPLATIN dosage: unknown. During the same period patient was treated with FLUOROURACIL, GRANISETRON, DEXAMETHASONE, OMEPRAZOLE, ZOFRAN, ZOLPIDEM TARTRATE, FORTASEC. Patient was hospitalized. Patient recovered.

CISPLATIN problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 12, 2007. Male patient, 57 years of age, was diagnosed with gastric cancer, anaemia, hypokalaemia, diarrhoea and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: dehydration, febrile neutropenia, malignant neoplasm progression, multi-organ failure. CISPLATIN dosage: unknown. During the same period patient was treated with IRON SULPHATETHIAMIN COMPOUND, POTASSIUM SUPPLEMENT, LOPERAMIDE. Patient was hospitalized. Patient died on 11/21/2006.

Consumer or non-health professional from IRELAND reported CISPLATIN problem on Feb 13, 2007. Male patient, 60 years of age, was diagnosed with gastric cancer, cancer pain, diabetes mellitus, constipation, prophylaxis of nausea and vomiting, stomatitis and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: cholangitis, malignant neoplasm progression, upper gastrointestinal haemorrhage. CISPLATIN dosage: unknown. During the same period patient was treated with FLUOROURACIL, INFUMORPH, GLICLAZIDE, METFORMIN, DOMPERIDONE, ORAMORPH, DIFFLAM. Patient was hospitalized. Patient died on 02/27/2006.

CISPLATIN problem was reported by a Health Professional from ITALY on Feb 05, 2007. Male patient, 39 years of age, was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: electrocardiogram st segment elevation, fatigue, hypotension, myocardial ischaemia, ventricular arrhythmia. CISPLATIN dosage: unknown. During the same period patient was treated with FLUOROURACIL. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported CISPLATIN problem on Feb 12, 2007. Male patient, 54 years of age, was diagnosed with tongue carcinoma stage iii and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: renal failure acute. CISPLATIN dosage: 100 MG/M2=183 MG FIRST CYCLE IV. Patient recovered.

CISPLATIN problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 12, 2007. Female patient, weighting 144.0 lb, was diagnosed with endometrial cancer recurrent, endometrial cancer stage iii, endometrial cancer stage iv and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: neutrophil count decreased, white blood cell count decreased. CISPLATIN dosage: 86 MG. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE, TAXOL. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CISPLATIN problem on Feb 09, 2007. Male patient, 58 years of age, was diagnosed with gastric cancer, diabetes mellitus, prophylaxis against gastrointestinal ulcer, gastrointestinal pain, anxiety, abdominal pain and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: cardio-respiratory arrest, gastric haemorrhage, multi-organ failure, renal failure. CISPLATIN dosage: unknown. During the same period patient was treated with DIANBEN, ULCERAL, SPASMOCTYL, LEXATIN, XUMADOL. Patient was hospitalized. Patient died on 08/08/2006.

CISPLATIN problem was reported by a Health Professional from UNITED STATES on Feb 20, 2007. Male patient, weighting 260.5 lb, was diagnosed with neoplasm malignant and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: hyperkalaemia, renal failure acute. CISPLATIN dosage: 170 MG IV / 21 DAYS. During the same period patient was treated with DOCETAXEL. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported CISPLATIN problem on Feb 12, 2007. Female patient, 63 years of age, was diagnosed with ovarian cancer metastatic and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: intestinal prolapse, post procedural complication. CISPLATIN dosage: unknown. During the same period patient was treated with PACLITAXEL, DOCETAXEL. Patient was hospitalized. Patient recovered.

CISPLATIN problem was reported by a Health Professional from UNITED STATES on Feb 13, 2007. Male patient, 62 years of age, weighting 156.5 lb, was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: dehydration, dysphagia, infection, lymphopenia, neutrophil count, opportunistic infection, pain, stomatitis, white blood cell count decreased. CISPLATIN dosage: unknown. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CISPLATIN problem on Feb 21, 2007. Female patient, weighting 103.6 lb, was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: neutropenia. CISPLATIN dosage: 68 MG. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE, TAXOL. Patient was hospitalized. Patient recovered.

CISPLATIN problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 21, 2007. Female patient, weighting 207.5 lb, was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: constipation, nausea, vomiting. CISPLATIN dosage: 100 MG. During the same period patient was treated with NAVELBINE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CISPLATIN problem on Feb 21, 2007. Female patient, weighting 196.4 lb, was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia, pneumonia. CISPLATIN dosage: 97 MG. During the same period patient was treated with TAXOL. Patient recovered.

CISPLATIN problem was reported by a Consumer or non-health professional from GERMANY on Feb 07, 2007. Male patient, 65 years of age, was diagnosed with gastric cancer and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: condition aggravated, conjunctivitis. CISPLATIN dosage: CYCLE 1 (159 MG, 1 IN 28 D) (159 MG) INTRAVENOUS DRIP. During the same period patient was treated with FLUOROURACIL, AMPHOTERICIN B, DEXPANTHENOL, FLUCONAZOLE, NEOTRACIN, AZIDAMFENICOL. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported CISPLATIN problem on Feb 16, 2007. Male patient, 42 years of age, was diagnosed with non-small cell lung cancer and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: pneumonitis. CISPLATIN dosage: unknown. During the same period patient was treated with GEMCITABINE, DEXAMETHASONE, POTASSIUM CHLORIDE, MAGNESIUM, FUROSEMIDE, APREPITANT, METOCLOPRAMIDE. Patient was hospitalized. Patient recovered.

CISPLATIN problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 15, 2007. Female patient, 60 years of age, was diagnosed with metastatic gastric cancer, vitamin supplementation and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: dehydration. CISPLATIN dosage: unknown. During the same period patient was treated with FLUOROURACIL, VITAMIN B. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CISPLATIN problem on Feb 16, 2007. Male patient, 63 years of age, weighting 176.4 lb, was diagnosed with non-small cell lung cancer and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: dehydration. CISPLATIN dosage: unknown. During the same period patient was treated with GEMCITABINE, ACENOCOUMAROL, CITALOPRAM, DIAZEPAM, HYDROCHLOROTHIAZIDE, NIFEDIPINE, PARACETAMOL. Patient was hospitalized. Patient recovered.

CISPLATIN problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 22, 2007. Female patient, weighting 154.0 lb, was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: bacterial infection, blood culture positive, chills, dehydration, dyspnoea, female genital tract fistula, haemorrhage, hydronephrosis, hypocalcaemia. CISPLATIN dosage: 50 MG. During the same period patient was treated with TAXOL. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from IRELAND reported CISPLATIN problem on Feb 14, 2007. Male patient, 60 years of age, was diagnosed with gastric cancer and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: iliac artery thrombosis. CISPLATIN dosage: unknown. Patient was hospitalized. Patient recovered.

CISPLATIN problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 02, 2007. Female patient, weighting 154.0 lb, was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: bacterial infection, blood culture positive, chills, dehydration, diarrhoea, dyspnoea, female genital tract fistula, haemorrhage, hydronephrosis. CISPLATIN dosage: 50 MG. During the same period patient was treated with TAXOL. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CISPLATIN problem on Feb 23, 2007. Female patient, weighting 109.0 lb, was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: neutropenia, white blood cell count decreased. CISPLATIN dosage: 75 MG. During the same period patient was treated with TOPOTECAN, DIPHENHYDRAMINE, FENTANYL TRANSDERMAL SYSTEM, MARINOL, METOCLOPRAMIDE, MORPHINE, ONDANSETRON. Patient recovered.

CISPLATIN problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 23, 2007. Female patient, weighting 109.0 lb, was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: neutropenia, white blood cell count abnormal, white blood cell count decreased. CISPLATIN dosage: 75 MG. During the same period patient was treated with TOPOTECAN, DIPHENHYDRAMINE, FENTANYL, MARINOL, METOCLOPRAMIDE, MORPHINE, ONDANSETRON. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CISPLATIN problem on Feb 16, 2007. Male patient, 69 years of age, was diagnosed with metastatic gastric cancer, hypertension, insomnia, prophylaxis, pain, mucosal inflammation and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: leukopenia, mucosal inflammation, neutropenia, thrombocytopenia. CISPLATIN dosage: unknown. During the same period patient was treated with FLUOROURACIL, COZAAR, ORFIDAL, OMEPRAZOLE, SEVREDOL, DIFLUCAN. Patient was hospitalized. Patient recovered.

CISPLATIN problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 15, 2007. Male patient, 67 years of age, weighting 154.3 lb, was diagnosed with lung neoplasm malignant, analgesic effect, prophylaxis, cough, vasodilation procedure and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: dyspnoea, renal failure. CISPLATIN dosage: unknown. During the same period patient was treated with ALIMTA, FOLIC ACID, TRAMADOL, ENALAPRIL MALEATE, RANITIDINE, CODEINE, CILOSTAZOL, VITAMIN B. Patient died on 02/06/2005.

Consumer or non-health professional from UNITED KINGDOM reported CISPLATIN problem on Feb 14, 2007. Male patient, child 6 years of age, was diagnosed with primitive neuroectodermal tumour and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: eye pain, optic atrophy, visual acuity reduced. CISPLATIN dosage: unknown. During the same period patient was treated with ETOPOSIDE, CYCLOPHOSPHAMIDE, VINCRISTINE. Patient recovered.

CISPLATIN problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 28, 2007. Female patient, weighting 207.5 lb, was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: constipation, hypokalaemia, hyponatraemia, nausea, renal failure acute, small intestinal obstruction, vomiting. CISPLATIN dosage: 100 MG. During the same period patient was treated with NAVELBINE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CISPLATIN problem on Feb 28, 2007. Female patient, weighting 156.3 lb, was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: neutropenia, pyrexia, sinusitis. CISPLATIN dosage: 92 MG. During the same period patient was treated with GEMCITABINE. Patient was hospitalized. Patient recovered.

CISPLATIN problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 20, 2007. Female patient, 51 years of age, was diagnosed with gastric cancer, anaemia, cancer pain and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: bronchopneumonia, haemorrhage, metastases to ovary, metastases to peritoneum, multi-organ failure, septic shock, tumour perforation. CISPLATIN dosage: unknown. During the same period patient was treated with FLUOROURACIL, FERRUM, BUPRENORPHINE. Patient was hospitalized. Patient died on 06/25/2006.

Consumer or non-health professional from IRELAND reported CISPLATIN problem on Feb 20, 2007. Male patient, 67 years of age, was diagnosed with gastric cancer and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: pulmonary embolism. CISPLATIN dosage: unknown. Patient was hospitalized. Patient recovered.

CISPLATIN problem was reported by a Health Professional from UNITED STATES on Feb 20, 2007. Male patient, weighting 178.6 lb, was diagnosed with squamous cell carcinoma and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: dehydration. CISPLATIN dosage: unknown. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CISPLATIN problem on Feb 15, 2007. Male patient, 67 years of age, weighting 154.3 lb, was diagnosed with lung neoplasm malignant, analgesic effect, prophylaxis, cough, vasodilation procedure and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: dyspnoea, renal failure. CISPLATIN dosage: unknown. During the same period patient was treated with ALIMTA, FOLIC ACID, TRAMADOL, ENALAPRIL MALEATE, RANITIDINE, CODEINE, CILOSTAZOL, VITAMIN B. Patient died on 02/06/2005.

CISPLATIN problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 27, 2007. Male patient, 40 years of age, weighting 114.6 lb, was diagnosed with gastric cancer, deep vein thrombosis, abdominal pain upper and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: anaemia, deep vein thrombosis, hyperthermia. CISPLATIN dosage: unknown. During the same period patient was treated with FLUOROURACIL, WARFARIN, ACETAMINOPHEN, OMEPRAZOLE, ONDANSETRON, MANNITOL, CHLORIDE. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported CISPLATIN problem on Feb 20, 2007. Male patient, 64 years of age, weighting 260.1 lb, was diagnosed with neoplasm malignant and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, hyperkalaemia, renal failure, renal failure acute. CISPLATIN dosage: unknown. During the same period patient was treated with DOCETAXEL. Patient was hospitalized. Patient recovered.

CISPLATIN problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 21, 2007. Male patient, 66 years of age, weighting 103.6 lb, was diagnosed with non-small cell lung cancer and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: anorexia, asthenia. CISPLATIN dosage: unknown. During the same period patient was treated with GEMCITABINE, PANTOPRAZOLE, FORMOTEROL FUMARATE, FENTANYL, TIOTROPIUM BROMIDE, FENOTEROL HYDROBROMIDE, ACETYLCYSTEINE, DIHYDROCODEINE BITARTRATE. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported CISPLATIN problem on Feb 20, 2007. Male patient, weighting 178.6 lb, was diagnosed with squamous cell carcinoma and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: dehydration. CISPLATIN dosage: unknown. Patient was hospitalized. Patient recovered.

CISPLATIN problem was reported by a Consumer or non-health professional from IRELAND on Feb 23, 2007. Male patient, 57 years of age, was diagnosed with metastatic gastric cancer and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: pancreatitis acute. CISPLATIN dosage: unknown. During the same period patient was treated with FLUOROURACIL, ONDANSETRON. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported CISPLATIN problem on Feb 26, 2007. Male patient, child 6 years of age, was diagnosed with primitive neuroectodermal tumour and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: optic atrophy. CISPLATIN dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, ETOPOSIDE, VINCRISTINE. Patient recovered.

CISPLATIN problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 02, 2007. Female patient, weighting 230.8 lb, was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: anaemia, enterocutaneous fistula, malaise, nausea, neutropenia, pyrexia, rhinorrhoea, urinary tract infection, wound complication. CISPLATIN dosage: 100 MG. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE, TAXOL. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CISPLATIN problem on Feb 22, 2007. Male patient, 71 years of age, was diagnosed with metastatic gastric cancer, myocardial infarction and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: peritonitis, thrombocytopenia. CISPLATIN dosage: unknown. During the same period patient was treated with FLUOROURACIL, ASPIRIN, DILTIAZEM. Patient was hospitalized. Patient died on 04/05/2006.

CISPLATIN problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 22, 2007. Male patient, 58 years of age, was diagnosed with gastric cancer, diabetes mellitus, prophylaxis against gastrointestinal ulcer, gastrointestinal pain, anxiety, abdominal pain and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: cardio-respiratory arrest, gastric haemorrhage, multi-organ failure, renal failure. CISPLATIN dosage: unknown. During the same period patient was treated with DIANBEN, ULCERAL, SPASMOCTYL, LEXATIN, XUMADOL. Patient was hospitalized. Patient died on 08/08/2006.

Consumer or non-health professional from UNITED KINGDOM reported CISPLATIN problem on Mar 01, 2007. Female patient, 53 years of age, was diagnosed with squamous cell carcinoma and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: stomatitis. CISPLATIN dosage: unknown. During the same period patient was treated with LAPATINIB. Patient was hospitalized. Patient recovered.

CISPLATIN problem was reported by a Health Professional from UNITED STATES on Feb 26, 2007. Male patient, 60 years of age, was diagnosed with oesophageal adenocarcinoma, diabetes mellitus, blood pressure, insomnia, neuropathy and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: renal failure acute. CISPLATIN dosage: unknown. During the same period patient was treated with FLUOROURACIL, METFORMIN, COUMADIN, NORVASC, AMBIEN, LASIX, NEURONTIN, INSULIN. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported CISPLATIN problem on Mar 02, 2007. Female patient, weighting 173.1 lb, was diagnosed with tonsil cancer and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: dehydration, mucosal inflammation, pain. CISPLATIN dosage: 50 MG/M2 IV Q3WKS. During the same period patient was treated with CETUXIMAB. Patient was hospitalized. Patient recovered.

CISPLATIN problem was reported by a Health Professional from IRELAND on Feb 23, 2007. Male patient, 69 years of age, was diagnosed with gastric cancer, gastrooesophageal reflux prophylaxis, depression and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: syncope. CISPLATIN dosage: unknown. During the same period patient was treated with OMEPRAZOLE, LEXAPRO. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CISPLATIN problem on Mar 05, 2007. Male patient, 57 years of age, was diagnosed with gastric cancer, anaemia, hypokalaemia, diarrhoea and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: dehydration, febrile neutropenia, malignant neoplasm progression. CISPLATIN dosage: unknown. During the same period patient was treated with IRON SULPHATETHIAMIN COMPOUND, POTASSIUM SUPPLEMENT, LOPERAMIDE. Patient was hospitalized. Patient died on 11/21/2006.

CISPLATIN problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 02, 2007. Female patient, weighting 230.8 lb, was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: anaemia, enterocutaneous fistula, malaise, nausea, neutropenia, open wound, pain, pyrexia, rhinorrhoea. CISPLATIN dosage: 100 MG. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE, TAXOL. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported CISPLATIN problem on Mar 06, 2007. Male patient, 46 years of age, was diagnosed with gastric cancer, antifungal prophylaxis, pain, gout, anxiety, mucosal inflammation, nausea and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia. CISPLATIN dosage: unknown. During the same period patient was treated with FLUOROURACIL, DIFLUCAN, ROXANOL, ALLOPURINOL, ATIVAN, MOUTHWASH, FENTANYL, COMPAZINE. Patient was hospitalized. Patient recovered.

CISPLATIN problem was reported by a Consumer or non-health professional from GERMANY on Mar 06, 2007. Male patient, 57 years of age, was diagnosed with squamous cell carcinoma and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: dehydration, haemoglobin decreased, hypokalaemia. CISPLATIN dosage: unknown. During the same period patient was treated with FLUOROURACIL. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from HUNGARY reported CISPLATIN problem on Mar 02, 2007. Female patient, 68 years of age, was diagnosed with metastatic gastric cancer, anorexia, hypertension, diabetes mellitus, dyspepsia and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: anaemia, asthenia, hyperglycaemia. CISPLATIN dosage: unknown. During the same period patient was treated with FLUOROURACIL, MEGACE, NORMODIPINE, BETALOC, GLIBENCLAMIDE, ISOSOURCE, FAMOTIDINE. Patient was hospitalized. Patient recovered.

CISPLATIN problem was reported by a Health Professional from UNITED STATES on Mar 02, 2007. Female patient, 66 years of age, was diagnosed with tonsil cancer, laryngeal cancer and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: creatinine renal clearance decreased, malignant neoplasm progression. CISPLATIN dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, METHOTREXATE, BLEOMYCIN, VINCRISTINE SULPHATE. Patient died.

Health Professional from UNITED STATES reported CISPLATIN problem on Mar 02, 2007. Female patient, 73 years of age, was diagnosed with squamous cell carcinoma and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased. CISPLATIN dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, METHOTREXATE, THIOGUANINE. Patient recovered.

CISPLATIN problem was reported by a Health Professional from UNITED STATES on Mar 07, 2007. Female patient, 61 years of age, was diagnosed with gastric cancer, pain, prophylaxis, insomnia, constipation, mouth ulceration and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: anaemia, haemorrhage, hypokalaemia, malignant neoplasm progression, neutropenia, renal failure. CISPLATIN dosage: unknown. During the same period patient was treated with FLUOROURACIL, TRAMACET, NEXIUM, ZOLPIDEM, LAXETTE, DULCOLAX, MYCOSTATIN. Patient was hospitalized. Patient died.

Consumer or non-health professional from UNITED STATES reported CISPLATIN problem on Mar 06, 2007. Female patient, weighting 103.6 lb, was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: neutropenia. CISPLATIN dosage: 68 MG. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE, TAXOL. Patient was hospitalized. Patient recovered.

CISPLATIN problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 06, 2007. Female patient, weighting 101.4 lb, was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: neutropenia, pyrexia. CISPLATIN dosage: 68 MG. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE, TAXOL. Patient was hospitalized. Patient recovered.

Health Professional from IRELAND reported CISPLATIN problem on Feb 21, 2007. Male patient, 62 years of age, was diagnosed with squamous cell carcinoma and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: chills, fatigue, pyrexia. CISPLATIN dosage: unknown. During the same period patient was treated with FLUOROURACIL. Patient was hospitalized. Patient recovered.

CISPLATIN problem was reported by a Physician from JAPAN on Feb 23, 2007. Female patient, 53 years of age, was diagnosed with ovarian epithelial cancer, interstitial lung disease and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: interstitial lung disease, large intestine perforation, neoplasm progression. CISPLATIN dosage: 85 MG ON DAY 1,. During the same period patient was treated with PREDNISOLONE, METHYLPREDNISOLONE, IRINOTECAN. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CISPLATIN problem on Mar 07, 2007. Female patient, weighting 154.3 lb, was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia, pulmonary embolism. CISPLATIN dosage: 70 MG. Patient was hospitalized. Patient recovered.

Showing 1-75 of 1173 Next >

Ask Our Patient Community about CISPLATIN

Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

This drug has as active FDA Safety Alert This drug has an active FDA Safety Alert
A
Abacavir sulfate
Abatacept
Abilify
Acamprosate calcium
AccuprilThis drug has as active FDA Safety Alert
AccutaneThis drug has as active FDA Safety Alert
AceonThis drug has as active FDA Safety Alert
Aciphex
Actiq (fentanyl citrate)
ActimmuneThis drug has as active FDA Safety Alert
(aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b)
ActonelThis drug has as active FDA Safety Alert (risedronate)
Actoplus MetThis drug has as active FDA Safety Alert (pioglitazone)
ActosThis drug has as active FDA Safety Alert (pioglitazone)
AcuTect (technetium Tc 99m apcitide)
Adefovir dipivoxil
Advair Diskus(Fluticasone propionate; Salmeterol xinafoate)
AdderallThis drug has as active FDA Safety Alert (amphetamine salts)
Agenerase (amprenavir)
Aggrastat (tirofiban)
Alamast (pemirolast)
AlendronateThis drug has as active FDA Safety Alert
AlemtuzumabThis drug has as active FDA Safety Alert
AleveThis drug has as active FDA Safety Alert (naproxen sodium)
Alfuzosin
Alinia (nitazoxanide)
Alimta (pemetrexed)
Alitretinoin
Almotriptan malateThis drug has as active FDA Safety Alert
Alosetron hydrochloride
Aloxi (palonosetron)
Alrex (loteprednol etabonate)
AltaceThis drug has as active FDA Safety Alert (ramipril)
Ambien (zolpidem tartrate)
AmergeThis drug has as active FDA Safety Alert (naratriptan)
Aminolevulinic acid
AmiodaroneThis drug has as active FDA Safety Alert
Amitiza (lubiprostone)
AmnesteemThis drug has as active FDA Safety Alert (isotretinoin)
Amphadase (hyaluronidase)
luronidase)
Amphetamine saltsThis drug has as active FDA Safety Alert
Amprenavir
AnaproxThis drug has as active FDA Safety Alert (naproxen sodium)
Angiomax (bivalirudin)
Anidulafungin
Antagon (ganirelix acetate)
Anthelios SX (avobenzone, ecamsule, octocrylene)
Apidra (insulin glulisine recombinant)
Apokyn (apomorphine)
Aprepitant
Aprotinin
Aptivus (tipranavir)
AranespThis drug has as active FDA Safety Alert (darbepoetin alpha)
Arava (leflunomide)
Arformoterol

Argatroban
ArediaThis drug has as active FDA Safety Alert (pamidronate)
Aripiprazole
Arixtra (fondaparinux)
Aromasin (exemestane)
Arranon (nelarabine)
Arsenic trioxide
Aspirin
Atacand (candesartan cilexetil)
Atazanavir sulfate
AtomoxetineThis drug has as active FDA Safety Alert
Avastin (bevacizumab)
Avelox (moxifloxacin)
Avobenzone, Ecamsule, Octocrylene
Avodart (dutasteride)
Avonex (interferon beta-1a)
AxertThis drug has as active FDA Safety Alert (almotriptan malate)
Azacitidine
Azilect (rasagiline)
Azopt (brinzolamide)

back to top

B
Balsalazide disodium
Baraclude (entecavir)
BenazeprilThis drug has as active FDA Safety Alert
Benicar (olmesartan medoxomil)
Bevacizumab
Bexarotene
BextraThis drug has as active FDA Safety Alert (valdecoxib)
BiaxinThis drug has as active FDA Safety Alert (clarithromycin)
Bimatoprost
Bivalirudin
BonivaThis drug has as active FDA Safety Alert (ibandronate)
Bortezomib
Brinzolamide
Brovana (arformoterol)
BupropionThis drug has as active FDA Safety Alert
Butisol sodium
Byetta (exenatide)


back to top

C
Calfactant
CampathThis drug has as active FDA Safety Alert (alemtuzumab)
Campral (acamprosate calcium)
Cancidas (caspofungin)
Candesartan cilexetil
Capecitabine
CapotenThis drug has as active FDA Safety Alert (captopril)
CaptoprilThis drug has as active FDA Safety Alert
CarbamazepineThis drug has as active FDA Safety Alert
CarbatrolThis drug has as active FDA Safety Alert (carbamazepine)
Carbrital (pentobarbital and carbromal)
Caspofungin
Cefditoren pivoxil
CefepimeThis drug has as active FDA Safety Alert
CeftriaxoneThis drug has as active FDA Safety Alert
CelebrexThis drug has as active FDA Safety Alert (celecoxib)
CelecoxibThis drug has as active FDA Safety Alert
CelexaThis drug has as active FDA Safety Alert (citalopram hydrobromide)
Cetrorelix acetate
Cetrotide (cetrorelix acetate)
Cetuximab
Cevimeline
ChantixThis drug has as active FDA Safety Alert (varenicline)
Cialis (tadalafil)
Cilostazol
Cinacalcet
Cirlesonide
CitalopramThis drug has as active FDA Safety Alert
ClaravisThis drug has as active FDA Safety Alert (isotretinoin)
ClarithromycinThis drug has as active FDA Safety Alert
Clarinex (desloratadine)
Clolar (clofarabine)
Clofarabine
Clozapine
Clozaril (clozapine)
CodeineThis drug has as active FDA Safety Alert
Colazal (balsalazide disodium)
Colesevelam
ColistimethateThis drug has as active FDA Safety Alert
Coly-Mycin M (colistimethate)This drug has as active FDA Safety Alert
Comtan (entacapone)
Concerta (methylphenidate)
Conivaptan
CordaroneThis drug has as active FDA Safety Alert (amiodarone)
CrestorThis drug has as active FDA Safety Alert (rosuvastatin calcium)
Cubicin (daptomycin)
Curosurf (poractant alfa)
CylertThis drug has as active FDA Safety Alert (pemoline)
CymbaltaThis drug has as active FDA Safety Alert (duloxetine)
CytotecThis drug has as active FDA Safety Alert (misoprostol)

back to top

D
Dacogen (decitabine)
Dalfopristin
Dalmane (flurazepam)
Daptomycin
Darbepoetin alphaThis drug has as active FDA Safety Alert
Darifenacin
Darunavir
Dasatinib
Daytrana (methylphenidate transdermal)
DDAVPThis drug has as active FDA Safety Alert (desmopressin)
DDAVP Nasal SprayThis drug has as active FDA Safety Alert (demopressin)
DDAVP Rhinal TubeThis drug has as active FDA Safety Alert (desmopressin)
DDVPThis drug has as active FDA Safety Alert (desmopressin
Decitabine
Deferasirox
Definity (perflutren lipid microspheres)
DepaconThis drug has as active FDA Safety Alert (valproate)
DepakeneThis drug has as active FDA Safety Alert (valproate)
DepakoteThis drug has as active FDA Safety Alert (valproate)
Desloratadine
DesmopressinThis drug has as active FDA Safety Alert
Detrol (tolterodine tartrate)
terodine tartrate)
Dexedrine (dextroamphetamine sulfate)
Dexmedetomidine
Dexmethylphenidate HCl
> Dextroamphetamine sulfate
Diastat AcuDialThis drug has as active FDA Safety Alert
Diazepam rectal gelThis drug has as active FDA Safety Alert
DidronelThis drug has as active FDA Safety Alert (etidronate)
DiprivanThis drug has as active FDA Safety Alert (propofol)
Dofetilide
Doral (quazepam)
Doxercalcif
Drospirenone
DuloxetineThis drug has as active FDA Safety Alert
DuragesicThis drug has as active FDA Safety Alert (fentanyl transdermal system)
Dutasteride

back to top

E

Eculizumab
Edetate disodium
Efalizumab
Efavirenz
EffexorThis drug has as active FDA Safety Alert (venlafaxine)
Elestat (epinastine)
EletriptanThis drug has as active FDA Safety Alert
Elidel (pimecrolimus)
Ellence (epirubicin)
Eloxatin (oxaliplatin)
Emend (aprepitant)
Emtricitabine
Emtriva (emtricitabine)
Enablex (darifenacin)
Enalapril / EnalaprilatThis drug has as active FDA Safety Alert
Endrate (edetate disodium)
Enfuvirtide
Entacapone
Entecavir
Epinastine
Epirubicin
Eplerenone
Epoetin alfaThis drug has as active FDA Safety Alert
EpogenThis drug has as active FDA Safety Alert (epoetin alfa)
Eptifibatide
EquetroThis drug has as active FDA Safety Alert (carbamazepine)
Eraxis (anidulafungin)
Erbitux (cetuximab)
Ertaczo (sertaconazole)
EscitalopramThis drug has as active FDA Safety Alert
Estazolam
Eszopiclone
Ethchlorvynol

Ethinyl estradiol
EtidronateThis drug has as active FDA Safety Alert
Evoxac (cevimeline)
Exelon (rivastigmine tartrate)
Exenatide
Exjade (deferasirox)
Exemestane
Extraneal (icodextrin)
Ezetimibe
Ezetimibe/simvastatin

back to top

F
Factive (gemifloxacin mesylate)
Faslodex (fulvestrant)
FelbamateThis drug has as active FDA Safety Alert
FelbatolThis drug has as active FDA Safety Alert (felbamate)
Fentanyl buccal tabletsThis drug has as active FDA Safety Alert
Fentanyl citrate
Fentanyl transdermal systemThis drug has as active FDA Safety Alert
FentoraThis drug has as active FDA Safety Alert (fentanyl buccal tablets)
Ferrlecit (sodium ferric gluconate complex)
Fleet Accu-PrepThis drug has as active FDA Safety Alert (sodium phosphate)
Fleet Phospho-SodaThis drug has as active FDA Safety Alert (sodium phosphate)
FluoxetineThis drug has as active FDA Safety Alert
Flurazepam
Fluticasone propionate
FluvoxamineThis drug has as active FDA Safety Alert
Focalin (dexmethylphenidate)
Focalin XR (dexmethylphenidate)
Fomivirsen
Fondaparinux
Foradil (formoterol fumarate)
Formoterol fumarate
FosamaxThis drug has as active FDA Safety Alert (alendronate)
FosinoprilThis drug has as active FDA Safety Alert
FrovaThis drug has as active FDA Safety Alert (frovatriptan succinate)
Frovatriptan succinateThis drug has as active FDA Safety Alert
Fulvestrant
Fuzeon (enfuvirtide)

G
GabapentinThis drug has as active FDA Safety Alert
GabitrilThis drug has as active FDA Safety Alert (tiagabine)
Gadobenate DimeglumineThis drug has as active FDA Safety Alert
GadodiamideThis drug has as active FDA Safety Alert
GadoliniumThis drug has as active FDA Safety Alert
Gadopentetate DimeglumineThis drug has as active FDA Safety Alert
GadoteridolThis drug has as active FDA Safety Alert
GadoversetamideThis drug has as active FDA Safety Alert
GalantamineThis drug has as active FDA Safety Alert
Ganirelix acetate
GatifloxacinThis drug has as active FDA Safety Alert
GefitinibThis drug has as active FDA Safety Alert
Gemifloxacin mesylate
Gemtuzumab ozogamicin
Geodon (ziprasidone)
Gleevec (imatinib mesylate)

back to top

H
Halcion (triazolam)
HaldolThis drug has as active FDA Safety Alert (haloperidol)
Haloperidol
This drug has as active FDA Safety Alert
Hectorol (doxercalcif)
Hepsera (adefovir dipivoxil)
Hyaluronidase
Hydase (hyaluronidase)
Human Secretin

back to top

I
IbandronateThis drug has as active FDA Safety Alert
Ibuprofen
Icodextrin
Iloprost
Imatinib mesylate
Increlex (Mecasermin [rDNA origin]
Infasurf Preservative Free (calfactant)
ImitrexThis drug has as active FDA Safety Alert (sumatriptan)
Innohep (tinzaparin)
Inspra (eplerenone)
Insulin Aspart recombinant
Insulin Detemir recombinant
Insulin Glargine recombinant

Insulin Glulisine recombinant

Intron A (interferon alfa-2b)
Integrilin (eptifibatide)
ifibatide)
Interferon alfa-2b
Interferon beta-1a
Interferon gamma-1bThis drug has as active FDA Safety Alert
Invega (paliperidone)
Iplex  (mecasermin rinfabate)
IressaThis drug has as active FDA Safety Alert (gefitinib)
IsotretinoinThis drug has as active FDA Safety Alert

back to top

J
Januvia (sitagliptin phosphate)

back to top

K
Kaletra (lopinavir; ritonavir)
Kepivance (palifermin)
KeppraThis drug has as active FDA Safety Alert (levetiracetam)
Ketek (telithromycin)
Ketotifen fumarate

back to top

L
LamictalThis drug has as active FDA Safety Alert (lamotrigine)
LamotrigineThis drug has as active FDA Safety Alert
Lantus (insulin glargine recombinant)
Leflunomide
Lenalidomide
Lepirudin recombinant
Levalbuterol
Levemir (insulin detemir recombinant)
LevetiracetamThis drug has as active FDA Safety Alert
Levitra (vardenafil)
Levonorgestrel
Levothyroxine sodium
Levulan Kerastick (aminolevulinic acid)
LexaproThis drug has as active FDA Safety Alert (escitalopram)
Lindane
Linezolid
This drug has as active FDA Safety Alert
LisinoprilThis drug has as active FDA Safety Alert
Lopinavir/ritonavir
Lotemax (loteprednol etabonate)
LotensinThis drug has as active FDA Safety Alert (benazepril)
Loteprednol etabonate
Lotronex (alosetron hydrochloride)
Lubiprostone
Lucentis (ranibizumab)
Lumigan (bimatoprost)
Lunestra (eszopiclone)
LyricaThis drug has as active FDA Safety Alert (pregabalin)

back to top

M
Macugen (pegaptanib)
MagnevistThis drug has as active FDA Safety Alert (gadopentetate dimeglumine)
Maraviroc
MavikThis drug has as active FDA Safety Alert (trandolapril)
MaxaltThis drug has as active FDA Safety Alert (rizatriptan benzoate)
MaxipimeThis drug has as active FDA Safety Alert (cefepime)
Mecasermin [rDNA origin]
Mecasermin-rinfabate
Meloxicam
Memantine
Metadate CD (methylphenidate HCl)
ylphenidate HCl)
Methylphenidate HCl
Methylphenidate transdermal
Mequinol
Micafungin
Micardis (telmisartan)
misartan)
MifeprexThis drug has as active FDA Safety Alert (mifepristone)
MifepristoneThis drug has as active FDA Safety Alert
Miglustat
MinirinThis drug has as active FDA Safety Alert (desmopressin)